help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 70, No. 1 49-55
doi:10.1210/jcem-70-1-49
Copyright © 1990 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FABER, J.
Right arrow Articles by JOHANSEN, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FABER, J.
Right arrow Articles by JOHANSEN, J. S.

Bone Gla Protein and Sex Hormone-Binding Globulin in Nontoxic Goiter: Parameters for Metabolic Status at the Tissue Level

JENS FABER, HANS PERRILD* and JULIA S. JOHANSEN

Department of Endocrinology E, Frederiksberg Hospital Frederiksberg DK-2000
The Department of Endocrinology F. Herlev University Hospital Herlev DK-2730
The Department of Clinical Chemistry, Glostrup Hospital Glostrup DK-2600 Denmark

Address all correspondence and requests for reprints to: Jens Faber, M.D., Department of Endocrinology F, Herlev University Hospital, DK-2730 Herlev, Denmark.

Several patients with nontoxic goiter have reduced serum TSH levels, as measured with new sensitive assays. Whether this is a sign of subclinical hyperthyroidism, thus having the potential of adverse effects on different organs with time, is not known.

We have measured serum levels of 2 markers of thyrometabolic status at the tissue level, bone {gamma}-carboxyglutamic acidcontaining protein (BGP), reflecting the function of osteoblasts, and sex hormone-binding globulin (SHBG), reflecting the function of hepatocytes, in 44 patients (41 women and 3 men) with nontoxic goiter (11 diffuse and 33 nodular goiters; serum T4, T3, free T4, and free T3 levels had been normal and stable for at least 0.5 yr). Serum TSH levels ranged from normal to unmeasurably low values (<0.05 mU/L). Serum TSH levels correlated negatively to serum BGP levels (r = –0.60; P < 0.001). Due to the postmenopausal surge in serum BGP levels, premenopausal women (n = 21) were tested separately without changing the significance (r = –0.53; P < 0.02). Expressing serum BGP values as a percentage of the mean value in control subjects of the same age and sex did not change the correlation (r = –0.63; P < 0.001). Six patients had serum BGP levels above the normal range, and patients with reduced serum TSH levels (<0.45 mU/L; n = 12) had significantly enhanced serum BGP levels [median, 1.53 nmol/L (range, 1.02–4.24) vs. 1.23 nmol/L (0.62–3.71); P < 0.05].

Serum TSH also correlated negatively to serum SHBG levels (r = –0.56; P < 0.001; women alone: r = –0.58; P < 0.001). Eight patients had serum SHBG levels above the normal range, and patients with reduced serum TSH levels had significantly enhanced serum SHBG levels, expressed as a percentage of the mean control value for the relevant sex [203% (range, 75–288) vs. 120% (42–317); P < 0.01].

It is concluded that the lower serum TSH levels in patients with nontoxic goiter, the higher are serum BGP and SHBG levels. This suggests a progressively generalized (not only pituitary) tissue overexposure to thyroid hormones, the lower the serum TSH levels. Therefore, the finding of a reduced serum TSH level in patients with nontoxic goiter might reflect supraphysiological levels of T4 and/or T3, which could possibly be harmful.

* Present address: Department of Medicine C, Bispebjerg Hospital, DK-2400.

Received January 1, 1989.




This article has been cited by other articles:


Home page
Endocr. Rev.Home page
B. Biondi and D. S. Cooper
The Clinical Significance of Subclinical Thyroid Dysfunction
Endocr. Rev., February 1, 2008; 29(1): 76 - 131.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
B. Biondi, E. A. Palmieri, M. Klain, M. Schlumberger, S. Filetti, and G. Lombardi
Subclinical hyperthyroidism: clinical features and treatment options
Eur. J. Endocrinol., January 1, 2005; 152(1): 1 - 9.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
Jesse C. and Michael
Borderline-Low Serum Thyrotropin Level Is Correlated With Increased Fasting Urinary Hydroxyproline Excretion
Arch Intern Med, February 1, 1992; 152(2): 360 - 364.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1990 by The Endocrine Society